Manufacturers Life Insurance Company, The Esperion Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $114 Billion
  • Q3 2025

A detailed history of Manufacturers Life Insurance Company, The transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 69,805 shares of ESPR stock, worth $202,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares
69,805
Previous 72,705 3.99%
Holding current value
$202,434
Previous $71,000 159.15%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$0.98 - $2.84 $2,842 - $8,236
-2,900 Reduced 3.99%
69,805 $184,000
Q2 2025

Aug 14, 2025
BUY
$0.73 - $1.41 $3,634 - $7,020
4,979 Added 7.35%
72,705 $71,000
Q1 2025

May 15, 2025
BUY
$1.44 - $2.34 $724 - $1,177
503 Added 0.75%
67,726 $97,000
Q4 2024

Feb 14, 2025
SELL
$1.61 - $3.83 $3,981 - $9,471
-2,473 Reduced 3.55%
67,223 $147,000
Q3 2024

Nov 13, 2024
SELL
$1.61 - $2.73 $2,885 - $4,892
-1,792 Reduced 2.51%
69,696 $114,000
Q2 2024

Aug 14, 2024
BUY
$1.84 - $3.24 $131,537 - $231,621
71,488 New
71,488 $158,000
Q2 2023

Aug 11, 2023
SELL
$1.2 - $1.76 $33,528 - $49,174
-27,940 Closed
0 $0
Q4 2022

Aug 11, 2023
BUY
$5.09 - $8.5 $8,301 - $13,863
1,631 Added 6.2%
27,940 $174,000
Q4 2022

Feb 13, 2023
BUY
$5.09 - $8.5 $8,301 - $13,863
1,631 Added 6.2%
27,940 $174,000
Q3 2022

Aug 11, 2023
SELL
$5.45 - $8.13 $1,389 - $2,073
-255 Reduced 0.96%
26,309 $176,000
Q3 2022

Nov 03, 2022
SELL
$5.45 - $8.13 $1,389 - $2,073
-255 Reduced 0.96%
26,309 $176,000
Q2 2022

Aug 11, 2023
BUY
$4.77 - $6.67 $4,894 - $6,843
1,026 Added 4.02%
26,564 $168,000
Q2 2022

Aug 15, 2022
BUY
$4.77 - $6.67 $4,894 - $6,843
1,026 Added 4.02%
26,564 $169,000
Q1 2022

Aug 11, 2023
SELL
$3.34 - $5.56 $8,022 - $13,355
-2,402 Reduced 8.6%
25,538 $118,000
Q1 2022

May 20, 2022
BUY
$3.34 - $5.56 $45,494 - $75,732
13,621 Added 114.3%
25,538 $118,000
Q4 2021

Feb 16, 2022
SELL
$4.81 - $11.92 $15,300 - $37,917
-3,181 Reduced 21.07%
11,917 $60,000
Q3 2021

Nov 12, 2021
SELL
$11.34 - $21.37 $4,467 - $8,419
-394 Reduced 2.54%
15,098 $182,000
Q2 2021

Aug 12, 2021
BUY
$19.4 - $28.71 $8,671 - $12,833
447 Added 2.97%
15,492 $328,000
Q1 2021

May 03, 2021
SELL
$25.12 - $36.89 $21,326 - $31,319
-849 Reduced 5.34%
15,045 $422,000
Q4 2020

Feb 12, 2021
BUY
$24.2 - $35.76 $16,794 - $24,817
694 Added 4.57%
15,894 $413,000
Q3 2020

Nov 09, 2020
SELL
$31.18 - $52.71 $8,543 - $14,442
-274 Reduced 1.77%
15,200 $565,000
Q2 2020

Aug 10, 2020
SELL
$30.04 - $51.31 $20,637 - $35,249
-687 Reduced 4.25%
15,474 $737,000
Q1 2020

May 15, 2020
BUY
$27.44 - $73.84 $29,607 - $79,673
1,079 Added 7.15%
16,161 $510,000
Q4 2019

Feb 14, 2020
SELL
$35.4 - $59.82 $18,868 - $31,884
-533 Reduced 3.41%
15,082 $899,000
Q3 2019

Nov 12, 2019
SELL
$34.47 - $47.53 $896 - $1,235
-26 Reduced 0.17%
15,615 $590,000
Q2 2019

Aug 14, 2019
BUY
$40.1 - $52.33 $17,122 - $22,344
427 Added 2.81%
15,641 $728,000
Q1 2019

May 13, 2019
BUY
$40.11 - $53.57 $45,444 - $60,694
1,133 Added 8.05%
15,214 $611,000
Q4 2018

Feb 14, 2019
SELL
$36.99 - $59.11 $44,942 - $71,818
-1,215 Reduced 7.94%
14,081 $648,000
Q3 2018

Nov 14, 2018
SELL
$40.74 - $51.41 $85,839 - $108,320
-2,107 Reduced 12.11%
15,296 $679,000
Q2 2018

Aug 14, 2018
BUY
$36.2 - $76.4 $155,189 - $327,526
4,287 Added 32.69%
17,403 $682,000
Q1 2018

May 15, 2018
SELL
$65.94 - $80.76 $2,571 - $3,149
-39 Reduced 0.3%
13,116 $949,000
Q4 2017

Feb 08, 2018
BUY
$43.47 - $67.43 $2,608 - $4,045
60 Added 0.46%
13,155 $867,000
Q3 2017

Nov 14, 2017
BUY
$43.8 - $52.77 $573,561 - $691,023
13,095
13,095 $655,000

Others Institutions Holding ESPR

# of Institutions
215
Shares Held
114M
Call Options Held
643K
Put Options Held
769K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $193M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email